Medications

FDA: Asthma drug Singulair to get 'black box' warning

Asthma and allergy drug montelukast—sold as a generic and under the brand name Singulair—will get a "boxed warning" over potential ties to neuropsychiatric effects, the U.S. Food and Drug Administration announced Wednesday.

Pediatrics

Breastfeeding and risks of allergies and asthma

In an Acta Paediatrica study, exclusive breastfeeding for the first 3 months was linked with a lower risk of respiratory allergies and asthma when children reached 6 years of age.

page 30 from 40